# US 2019/0316200 A1 · System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2019/0316200 A1
- Document ID: US20190316200A1
- Status: Published application
- Kind: A1
- Application number: 16/411,446
- Filed: 2019-05-14
- Published: 2019-10-17
- Earliest claimed: 2005-11-26
- Assignees: Natera, Inc.
- Applicants: Natera, Inc.
- Inventors: Matthew RABINOWITZ; Milena BANJEVIC; Zachary DEMKO; David JOHNSON
- Web page: https://patentgrep.com/patent/US20190316200A1

## CPC

- C12Q 1/6883: for diseases caused by alterations of genetic material
- C12Q 1/6827: for detection of mutation or polymorphism
- C12Q 1/6876: Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- G16B 20/00: ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B 20/20: Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
- G16B 20/40: Population genetics; Linkage disequilibrium
- G16B 25/00: ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B 30/00: ICT specially adapted for sequence analysis involving nucleotides or amino acids
- G16B 40/00: ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- C12Q 2600/118: Prognosis of disease development
- C12Q 2600/156: Polymorphic or mutational markers
- C12Q 2600/158: Expression markers
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- G16B: BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY

## Abstract

A system and method for determining the genetic data for one or a small set of cells, or from fragmentary DNA, where a limited quantity of genetic data is available, are disclosed. Genetic data for the target individual is acquired and amplified using known methods, and poorly measured base pairs, missing alleles and missing regions are reconstructed using expected similarities between the target genome and the genome of genetically related subjects. In accordance with one embodiment of the invention, incomplete genetic data is acquired from embryonic cells, fetal cells, or cell-free fetal DNA isolated from the mother's blood, and the incomplete genetic data is reconstructed using the more complete genetic data from a larger sample diploid cells from one or both parents, with or without genetic data from haploid cells from one or both parents, and/or genetic data taken from other related individuals.

## Claims

### Claim 1

A method for determining genetic data for DNA from a first individual, the method comprising:
isolating cell-free DNA from a biological sample of a second individual and amplifying at least 70 loci from the isolated cell-free DNA in a single reaction volume to obtain amplification products;
using high-throughput DNA sequencing to detect genetic material from the amplification products and produce genetic data for the at least 70 loci, wherein the genetic data is noisy due to a small amount of genetic material from a first individual; and
determining the most likely genetic data for DNA from the first individual.

### Claim 2 (depends on 1)

The method of claim 1, wherein the small amount of genetic material is from 0.3 ng or less of DNA.

### Claim 3 (depends on 1)

The method of claim 1, wherein the biological sample is a blood sample, and the small amount of genetic material is from cell-free DNA in the blood sample.

### Claim 4 (depends on 1)

The method of claim 1, wherein the noisy data comprises allele drop out errors.

### Claim 5 (depends on 1)

The method of claim 1, wherein the noisy data comprises measurement bias.

### Claim 6 (depends on 1)

The method of claim 1, wherein the noisy data comprises incorrect measurements.

### Claim 7 (depends on 1)

The method of claim 1, wherein the loci are SNP loci.

### Claim 8 (depends on 7)

The method of claim 7, wherein the confidence that each SNP is correctly called is at least 95%.

### Claim 9 (depends on 7)

The method of claim 7, wherein the confidence that each SNP is correctly called is at least 99%.

### Claim 10 (depends on 1)

The method of claim 1, wherein the genetic data has been obtained by amplifying and/or measuring the genetic material using tools and/or techniques selected from the group consisting of Polymerase Chain Reaction (PCR), Ligation-mediated PCR, degenerative oligonucleotide primer PCR, Multiple Displacement Amplification, allele-specific amplification techniques, and combinations thereof, and wherein one or more of the individual's genetic data has been measured using tools and or techniques selected from the group consisting of MOLECULAR INVERSION PROBES (MIPs) circularizing probes, other circularizing probes, Genotyping Microarrays, the TAQMAN SNP Genotyping Assay, other hydrolysis probes, the ILLUMINA Genotyping System, other genotyping assays, Sanger DNA sequencing, pyrosequencing, other methods of DNA sequencing, other high through-put genotyping platforms, fluorescent in-situ hybridization (FISH), and combinations thereof.

### Claim 11 (depends on 1)

The method of claim 1, further comprising normalizing the genetic data for differences in amplification and/or measurement efficiency between the loci.

### Claim 12 (depends on 1)

The method of claim 1, wherein the probability of each of the hypotheses is determined without use of a reference sample.
